Drugs in Class Action Litigation: Crestor

A study published in 2004 by the American Heart Association’s Journal, Circulation, Crestor was found to be approximately two to six times more likely to cause negative side effects over a one-year period as some of the other statins available on the market. These findings were based upon the number of side effects that had been reported to the FDA. The reporting of side effects of Crestor in its first year on the market included a much higher rate of serious side effects such as rhabdomyolysis and kidney damage than other statins on the market.

Read more

THE SITE ALSO HAS A FREE CASE EVALUATION!